Jing Xu

发表

Invited Review Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: a narrative review

M. Zheng, G. Targher, C. Byrne, 2022 .

Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly

Zhendong Liu, Hua Zhang, Weike Liu, 2022, Frontiers in Neurology.

The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism

Xiaoying Li, Zhiqiang Lu, Yumei Yang, 2020, International journal of endocrinology.

Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005–2014

T. Zhai, Jing Xu, Qi Chen, 2022, Frontiers in Endocrinology.

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms

Yuanlin Song, Chao-min Wu, C. Du, 2020, Signal Transduction and Targeted Therapy.

Role of high-salt diet in non-alcoholic fatty liver disease: a mini-review of the evidence

Jinghong Xu, Fei Mao, Jing Xu, 2021, European Journal of Clinical Nutrition.

Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients

Xin Gao, J. Xu, Mingfeng Xia, 2020, BMC Endocrine Disorders.

Hepatic Transcriptomics Reveals Reduced Lipogenesis in High-Salt Diet Mice

Yan Lu, Yao Li, Tiemin Liu, 2023, Genes.

Coffee Drinking and the Odds of Osteopenia and Osteoporosis in Middle-Aged and Older Americans: A Cross-Sectional Study in NHANES 2005-2014.

Jing Xu, Tianyu Zhai, 2024, Calcified tissue international.